Find practical information about diabetes treatment and management, including blood sugar monitoring, medications, lifestyle changes, complications and everyday diabetes care.
While alcohol does not diminish the effectiveness of oral GLP-1 drugs for obesity, it can heighten side effects and complicate treatment, experts caution, recommending careful management rather than outright abstinence. Alcohol does not appear to blunt the effect of oral…
Dexcom’s fifth season of Dexcom U features its largest roster yet, highlighting a shift in attitudes towards diabetes in sports, with more young athletes participating confidently and supported by advanced continuous glucose monitoring technology. Dexcom has launched the fifth season…
In a significant breakthrough, Eli Lilly’s oral GLP-1 drug orforglipron demonstrated superior blood sugar control and weight loss compared to oral semaglutide in a 52-week phase 3 trial, potentially expanding treatment options for adults with type 2 diabetes. Eli Lilly’s…
Zag Bio has launched its first human study of ZAG-101, an innovative therapy aiming to modify the disease process in type 1 diabetes by targeting the immune system through the thymus, marking its transition into clinical-stage development. Zag Bio said…
A new weekly diabetes meal plan emphasises flexibility and practical routines over rigid diets, offering personalised support for better blood sugar management. A weekly diabetes meal plan published by Diabetes Meal Plans is built around lower-carbohydrate dishes, leftovers and a…
Breakthrough T1D announces its inaugural clinical and research congress in Philadelphia, uniting global experts to advance treatments and move closer to a cure for type 1 diabetes. Breakthrough T1D has announced an inaugural clinical and research congress that it says…
The Nobel Prize in Physiology or Medicine, opening Nobel week, spotlights pioneering research on GLP-1 biology, obesity treatment, and sleep regulation, setting the stage for a competitive race among leading scientists. The award, worth 12 million Swedish kronor, recognises groundbreaking…
Loop Health’s India Workforce Health Index 2026 reveals Mumbai as the leading city with the highest prevalence of elevated blood-sugar levels among major Indian metros, indicating a growing metabolic health crisis across age and gender groups. Mumbai has emerged as…
Glenmark Pharmaceuticals has introduced its new semaglutide brand, GLIPIQ, in India at a significantly lower price point, aiming to expand access to advanced diabetes treatments and challenge existing premium products in the market. Glenmark Pharmaceuticals’ new semaglutide brand GLIPIQ has…
Research suggests that with proper preparation and advanced insulin delivery systems, young people with type 1 diabetes may safely observe prolonged religious fasts, challenging previous assumptions about risks involved. A new study from researchers at the Jerusalem College of Technology…
While recent studies suggest a potential link between GLP-1 receptor agonists and rare optic nerve damage, eye specialists emphasise that the overall risk remains extremely low and current treatment guidelines favour continued use with vigilance. Evidence from recent studies suggests…
Eli Lilly reports promising phase 2b results for a novel drug combo of eloralintide and tirzepatide, noting improved weight reduction and diabetes management in adults with obesity, paving the way for phase 3 trials. Eli Lilly’s experimental amylin receptor agonist…
